These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36995633)

  • 21. Development and application of CRISPR/Cas9 technologies in genomic editing.
    Zhang C; Quan R; Wang J
    Hum Mol Genet; 2018 Aug; 27(R2):R79-R88. PubMed ID: 29659822
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CRISPR-based epigenome editing: mechanisms and applications.
    Fadul SM; Arshad A; Mehmood R
    Epigenomics; 2023 Nov; 15(21):1137-1155. PubMed ID: 37990877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increasing the efficiency of CRISPR-Cas9-VQR precise genome editing in rice.
    Hu X; Meng X; Liu Q; Li J; Wang K
    Plant Biotechnol J; 2018 Jan; 16(1):292-297. PubMed ID: 28605576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CRISPR/Cas gene therapy.
    Zhang B
    J Cell Physiol; 2021 Apr; 236(4):2459-2481. PubMed ID: 32959897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Temperature effect on CRISPR-Cas9 mediated genome editing.
    Xiang G; Zhang X; An C; Cheng C; Wang H
    J Genet Genomics; 2017 Apr; 44(4):199-205. PubMed ID: 28412228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CRISPR-cas9 genome editing delivery systems for targeted cancer therapy.
    Ghaemi A; Bagheri E; Abnous K; Taghdisi SM; Ramezani M; Alibolandi M
    Life Sci; 2021 Feb; 267():118969. PubMed ID: 33385410
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CRISPR/Cas9-Mediated Genome Editing in Cancer Therapy.
    Ding S; Liu J; Han X; Tang M
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epigenome editing by CRISPR/Cas9 in clinical settings: possibilities and challenges.
    Pei WD; Zhang Y; Yin TL; Yu Y
    Brief Funct Genomics; 2020 May; 19(3):215-228. PubMed ID: 31819946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CRISPR-cas System as a Genome Engineering Platform: Applications in Biomedicine and Biotechnology.
    Hashemi A
    Curr Gene Ther; 2018; 18(2):115-124. PubMed ID: 29473500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An efficient DNA- and selectable-marker-free genome-editing system using zygotes in rice.
    Toda E; Koiso N; Takebayashi A; Ichikawa M; Kiba T; Osakabe K; Osakabe Y; Sakakibara H; Kato N; Okamoto T
    Nat Plants; 2019 Apr; 5(4):363-368. PubMed ID: 30911123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An Agrobacterium-Mediated CRISPR/Cas9 Platform for Genome Editing in Maize.
    Lee K; Zhu H; Yang B; Wang K
    Methods Mol Biol; 2019; 1917():121-143. PubMed ID: 30610633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene editing in clinical isolates of Candida parapsilosis using CRISPR/Cas9.
    Lombardi L; Turner SA; Zhao F; Butler G
    Sci Rep; 2017 Aug; 7(1):8051. PubMed ID: 28808289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CRISPR/Cas9 in plants: at play in the genome and at work for crop improvement.
    Hussain B; Lucas SJ; Budak H
    Brief Funct Genomics; 2018 Sep; 17(5):319-328. PubMed ID: 29912293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CRISPR-Directed Gene Editing Catalyzes Precise Gene Segment Replacement
    Sansbury BM; Wagner AM; Tarcic G; Barth S; Nitzan E; Goldfus R; Vidne M; Kmiec EB
    CRISPR J; 2019 Apr; 2():121-132. PubMed ID: 30998096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CRISPR/Cas genome editing perspectives for barley breeding.
    Kershanskaya OI; Yessenbaeva GL; Nelidova DS; Karabekova AN; Sadullaeva ZN
    Physiol Plant; 2022 May; 174(3):e13686. PubMed ID: 35451132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CRISPR/Cas9 gene editing and natural variation analysis demonstrate the potential for HvARE1 in improvement of nitrogen use efficiency in barley.
    Karunarathne SD; Han Y; Zhang XQ; Li C
    J Integr Plant Biol; 2022 Mar; 64(3):756-770. PubMed ID: 35014191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A status-quo review on CRISPR-Cas9 gene editing applications in tomato.
    Chandrasekaran M; Boopathi T; Paramasivan M
    Int J Biol Macromol; 2021 Nov; 190():120-129. PubMed ID: 34474054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CRISPR-Cas9-mediated genome editing in apple and grapevine.
    Osakabe Y; Liang Z; Ren C; Nishitani C; Osakabe K; Wada M; Komori S; Malnoy M; Velasco R; Poli M; Jung MH; Koo OJ; Viola R; Nagamangala Kanchiswamy C
    Nat Protoc; 2018 Dec; 13(12):2844-2863. PubMed ID: 30390050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An efficient CRISPR/Cas9 platform for targeted genome editing in rose (Rosa hybrida).
    Wang C; Li Y; Wang N; Yu Q; Li Y; Gao J; Zhou X; Ma N
    J Integr Plant Biol; 2023 Apr; 65(4):895-899. PubMed ID: 36460630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CRISPR-Cas9: from Genome Editing to Cancer Research.
    Chen S; Sun H; Miao K; Deng CX
    Int J Biol Sci; 2016; 12(12):1427-1436. PubMed ID: 27994508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.